Transplant in Medical Technology

WORLD'S First Robotic Assisted Kidney Transplant Performed at Saint Barnabas Medical Center

LIVINGSTON, N.J., June 4 /PRNewswire/ -- Transplant surgeon, Stuart R. Geffner, M.D., Director of Kidney and Pancreas Transplant Surgery, Saint Barnabas Health Care System Renal and Pancreas Transplant Division, is the first in the world to use the Intuitive Surgical's da Vinci(TM) Surgical System...

Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients

The results of these studies will be presented during the American Transplant Congress in Boston, MA May 30 - June 3, 2009 COLUMBIA, Md., May 31 /PRNewswire/ -- A study conducted at Westchester Medical Center in Valhalla, NY examined liver transplant recipients to determine whether the use o...

Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases

TAMPA, Fla., May 5 /PRNewswire-USNewswire/ -- The Tampa Lions Eye Institute for Transplant and Research, Inc. (LEITR) today announced plans to open a new 12,000-square-foot facility in Tampa, Florida. This state-of-the-art facility will offer high-volume, high-quality human ocular tissue for resea...

An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients

The results of the largest study performed to date will be presented during the International Society for Heart and Lung Transplantation Annual Meeting in Paris, France on April 24, 2009 COLUMBIA, Md., April 24 /PRNewswire/ -- Since it was cleared as an in vitro assessment of cell-mediate...

Fifth U.S. Hand Transplant Patient Heads Home to NY

LOUISVILLE, Ky., Feb. 17 /PRNewswire-USNewswire/ -- The United States' fifth hand transplant recipient, Jan "Erik" Hondusky, is heading back home to Massena, New York this week after a three-month stay in Louisville under the care of Kleinert Kutz and University of Louisville surgeons. (Ph...

ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients

EXTON, Pa., Feb. 13 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM ) today announced that its Phase 3 trial evaluating maribavir used as prophylaxis against cytomegalovirus (CMV) disease in liver transplant patients has been discontinued, and that all patients on study drug are ...

Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center

LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/ -- Kleinert Kutz and University of Louisville hand surgeons performed the fifth U.S. hand transplant on Messina, New York resident, Jan "Erik" Hondusky, at Louisville's Jewish Hospital Hand Care Center on Monday, November 24. The innovative proce...

New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients

Cylex's ImmuKnow(R) assay suggests clinical potential in independent study of pediatric liver transplant patients COLUMBIA, Md., Aug. 21 /PRNewswire/ -- Israeli et al.,* in an article just published in the peer-reviewed journal Liver Transplantation, have further developed our u...

Precise Low-Dose Drug Monitoring Essential for Long-Term Kidney Transplant Success

Study Highlights Performance of Abbott's ARCHITECT Tacrolimus Assay, Only Automated Transplant Monitoring Test that Meets International Standards for Low-Level Monitoring WASHINGTON, July 30 /PRNewswire-FirstCall/ -- The ability of blood tests to precisely measure very ...

University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients

New data presented at annual American Transplant Congress in Toronto MIAMI, June 2 /PRNewswire/ -- Manuel R. Carreno, MD, and colleagues in the Departments of Surgery and Pathology at the University of Miami - Lawrence Miller School of Medicine have corroborated the value of monitoring cell-...

Penn State Hershey Transplant Program Uses Assay to Monitor Cell-Mediated Immunity

Improvement Noted in Management of Transplant Recipients with Cancer HERSHEY, Pa., June 1 /PRNewswire/ -- The management of immunosuppression in post-transplant patients with cancer is challenging. Clinicians must balance the need to treat the malignancy effectively while simultaneously moni...

ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients

- Phase 3 Study in 681 Stem Cell Transplant Patients Represents First Pivotal Study on a New Antiviral CMV Therapy in Stem Cell Transplant in Over a Decade - - Company Also Provides Timing of Phase 3 Data Disclosure and Regulatory Submi...

Prospective Microbial Analysis of Bronchoalveolar Lavage Fluids with Immune Function Testing Can Distinguish Between Fungal Colonization and Fungal Disease In Lung Transplant Recipients

Data from 150 lung transplant patients demonstrates potential to improve management of risk for infection BOSTON, April 10 /PRNewswire/ -- A prospective analysis of data collected from 170 patients receiving lung transplantation at the University of Pittsburgh Medical Center...

Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients

BOSTON, April 10 /PRNewswire/ -- Data presented at this week's 28th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize t...

Independent Studies Report on Possible Roles for Cylex's Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients

Six different studies will report on use of ImmuKnow assay in presentations at the annual meeting of the International Society for Heart and Lung Transplantation COLUMBIA, Md., April 9 /PRNewswire/ -- Since it was initially cleared as an in vitro diagnostic techniqu...

New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting

BOSTON, April 9, 2008 /PRNewswire/ -- New devices and research for mechanical circulatory support in pediatrics from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Circulatory Support Program will be discussed at the International Society fo...

Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine

NEW YORK, Feb. 4 /PRNewswire/ -- There is a large and growing "treatment gap" between the number of patients worldwide who would benefit from an organ transplant and the number of organs available, a gap that is impacting transplant medicine markets, according to a new market research report f...

Northwestern Memorial Transplant Program Initiates New Study

Study seeks to wean certain kidney transplant recipients off anti-rejection drugs following surgery CHICAGO, Jan. 22 /PRNewswire-USNewswire/ -- After a transplant surgery, anti-rejection drugs for the organ recipient are a must, but with prolonged use can have serious side effects, includi...

Improved Cornea Surgery Technique Provides Enhanced Transplant Success

Researcher at American Academy of Ophthalmology Annual Meeting Describes Advance in Treatment of Endothelial Disease NEW ORLEANS, Nov. 12 /PRNewswire/ -- In a research presentation today at the American Academy of Ophthalmology's Annual Meeting, Massimo Busin, MD, department head ...

Sexual Function Affected by Stem Cell Transplant According to Long-Term Study

WASHINGTON, Sept. 18 /PRNewswire-USNewswire/ -- A long-term study found that a type of stem cell transplant used for patients with life-threatening diseases, such as leukemia and lymphoma, results in decreased sexual function and activity for recipients. Further, males are likely to recover fr...

Cleveland Clinic Surgeons Perform Nation's First Near-Total Face Transplant

Surgery Largest, Most Complex of Its Kind; 80 Percent of Trauma Patient's Face Transplanted CLEVELAND, Dec. 17 /PRNewswire/ -- A multi-disciplinary team of doctors and surgeons at Cleveland Clinic recently performed the first near-total face transplant in the United States. In ...

American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant

Study highlights: In a small study, miniaturized heart pumps helped keep children alive who were awaiting a heart transplant. The devices are not approved for general use in the United States. DALLAS, Sept. 30 /PRNewswire-USNewswire/ -- In a recent study, nine pediatric patients with sev...

Allegheny General Hospital Performs First Liver Transplant

28 year-old Mother of Three Recovering Well After November 1 Procedure PITTSBURGH, Pa., Nov. 15 /PRNewswire/ -- A 28 year-old Robinson Township woman has become the first patient to undergo liver transplantation surgery at Allegheny General Hospital (AGH). AGH officials said the surgery, whi...

Isotechnika's independent data monitoring committee conducts review of phase 2b kidney transplant trial

- Company Set to Host Evening Symposium at ATC - EDMONTON, March 27 /CNW/ - Isotechnika Inc. announced today that an independent data monitoring committee (DMC) has met and reviewed the interim data from the Phase 2b kidney transplant (PROMISE) trial. The review included 3 month data from ...

Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice with Transplant of Purified Donor Blood Stem Cells

SAN CARLOS, Calif.--(BUSINESS WIRE)--Apr 23, 2007 - Cellerant Therapeutics today announced the publication of data suggesting that established autoimmune disease can be reversed or stabilized by the transplantation of purified allogeneic (donated) hematopoietic (blood forming) stem cells (HSC) in a...

British Woman Celebrates a Year of Living Cancer-Free

...ally, really upset," she said of her second relapse. "I don't want to think about how it felt. I don't want to feel like that again." After the transplant failed, Ms. Scott lost hope that she would survive AML. She began preparing herself for death. "When you're in your 50s, you can think, 'At least I've...

World's First Cardiac Adult Stem Cell Patient Receives Infusion

...r following the outpatient procedure. Mark Slaughter, M.D., Chief of the Division of Cardiothoracic Surgery at UofL and Director of the Heart transplant and Mechanical Assist Device Program at Jewish Hospital, performed coronary artery bypass surgery on Jones on March 23. Jones suffered from congestive...

UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and Lymphoma Patients

...linical director of UPCI's Hematopoietic Stem Cell transplant Program. "Using umbilical cord blood stem cells instead of a traditional bone marrow transplant opens tremendous treatment possibilities for patie...more than half the number of patients in need of a transplant can't find matching bone marrow donors. Cord blood...

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

...course of treatment with orBec(R) (i.e., 30 days following cessation of treatment). The confirmatory Phase 3 clinical trial will be conducted at major transplant centers throughout the US and Canada. "We are very pleased to obtain a positive response from the EMEA regarding the design of our upcoming confi...

Afinitor(R) Phase II Data Show Positive Results for Patients With Multiple Types of Lymphoma, Leading to Phase III Trial

...verolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. Certican is not approved for use in the US. Afinitor important safety information ...

PARI Pharma Reports Successful Phase Ib Clinical Results for Inhaled Liposomal Cyclosporine A and Gains FDA Orphan Drug Designation for the Prevention and Treatment of Bronchiolitis Obliterans

...ermany. "The long-term survival rate for lung transplant patients could be greatly improved through an effe... Phase Ib clinical trial for L-CsA studied 12 lung transplant recipients, where five patients had double lung tr...n comparison, oral CsA (Neoral(R)) therapy in lung transplant patients leads to highly variable C(max) and AUC(0...

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

... CMV is the most serious viral infection affecting transplant patients BOSTON, June 1 /PRNewswire/ -- New... the first time today at the ninth annual American transplant Congress 2009 (ATC) demonstrate that doubling the ...ncidence of CMV disease by 56% in high-risk kidney transplant patients within the first year post-transplant. ...

Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy

...hese studies will be presented during the American transplant Congress in Boston , MA May 30 - June 3...e studies presented by researchers from the Starzl transplant Institute at the University of Pittsburgh Medica...lation, and is increasingly being adopted at organ transplant centers throughout the United States and abroad. T...

Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis

...f of patients do not respond to medical therapy. For some patients, a liver transplant cures the condition. But not all patients qualify for a transplant, and some transplant recipients experience a recurrence within five to 10 years. The study ...

Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support

...tem Cell Modulator Administered in Dual Cord Blood transplant for Hematologic Malignancy LA JOLLA, Calif., ...g the standard course of dual umbilical cord blood transplant in adult patients with hematologic malignancies, s...tients receiving a bone marrow or peripheral blood transplant must find a donor that matches at least five of th...

PARI Pharma's Nebulized DSCG Shows Results Similar to Inhaled Steroids in Asthma Studies Presented at ATS

...g product and are currently in clinical trials for cystic fibrosis, asthma, COPD, respiratory syncytial virus (RSV) infection, and treatments for lung transplant patients among other indications. PARI Pharma provides comprehensive inhalation drug development, including nebulizer formulation development and...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

...vice in helping to sustain patients awaiting heart transplant who are at risk of death due to end-stage left ven...staining technology to our patients awaiting heart transplant who are at risk of death due to end-stage left ven...lants annually, but less than 3,000 will receive a transplant each year. A large number of people who suffer fr...

HeartWare International Clinical Trial Shows 90% Survival at 180 Days

...ing a meaningful stimulus as we make the system more broadly available in our International markets and as we accelerate enrolment in our US Bridge to transplant clinical trial." * The data includes all patients through February 26, 2009. As of today, 3 patients have yet to pass the endpoint of the inte...

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

...vailable for sale outside of the United States. The pivotal U.S. Bridget to transplant DuraHeart Trial, involving up to 40 clinical sites and 140 patients is in p...ndidates for heart transplants annually, but less than 4,000 will receive a transplant each year. A large number of people who suffer from severe heart failure do...

Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib

...verolimus, which is available in different dosage strengths under the trade name Certican(R) for the prevention of organ rejection in heart and kidney transplant recipients. Certican was first approved in the EU in 2003. Certican is not approved for use in the US(1). For more information on Afinitor, visit...